1. Home
  2. ARMP vs BYND Comparison

ARMP vs BYND Comparison

Compare ARMP & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$8.06

Market Cap

295.5M

Sector

Health Care

ML Signal

N/A

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

N/A

Current Price

$0.77

Market Cap

269.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ARMP
BYND
Founded
N/A
2009
Country
United States
United States
Employees
61
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
295.5M
269.7M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
ARMP
BYND
Price
$8.06
$0.77
Analyst Decision
Strong Buy
Sell
Analyst Count
2
7
Target Price
$15.00
$0.83
AVG Volume (30 Days)
73.3K
84.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
24.69
EPS
N/A
N/A
Revenue
N/A
$275,496,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.74
$0.50
52 Week High
$14.98
$7.69

Technical Indicators

Market Signals
Indicator
ARMP
BYND
Relative Strength Index (RSI) 37.57 46.38
Support Level $7.43 $0.67
Resistance Level $12.11 $0.82
Average True Range (ATR) 1.12 0.08
MACD -0.22 -0.02
Stochastic Oscillator 14.20 11.11

Price Performance

Historical Comparison
ARMP
BYND

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: